---
title: "NRX Therapeutics (NRXP.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/NRXP.US/norm.md"
symbol: "NRXP.US"
name: "NRX Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/NRXP.US.md"
datetime: "2026-06-14T07:44:50.536Z"
locales:
  - [en](https://longbridge.com/en/quote/NRXP.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NRXP.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NRXP.US/norm.md)
---

# NRX Therapeutics (NRXP.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.0442 | 0.0124 | -0.2649 | -0.9803 | -0.3359 |
| ROE | 38.45% | -6.91% | 76.78% | 231.42% | 91.14% |
| 营业收入 | 1.07M | 983000.00 | 242000.00 | - | - |
| 净利润 | -1.43M | 360000.00 | -5.89M | -17.58M | -5.51M |
| 营业利润 | -4.75M | -4.59M | -4.12M | -3.73M | -3.75M |
| 毛利率 | 40.92% | 58.49% | 59.92% | - | - |
| 净利率 | -133.90% | 36.62% | -2433.88% | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 11.90M | 12.96M | 15.00M | 4.84M | 7.59M |
| 权益乘数 | -0.8615 | -0.8130 | -0.5823 | -0.1358 | -0.3017 |
| 每股净资产 | -0.4132 | -0.5027 | -0.9304 | -1.83 | -1.47 |
| 资产周转率 | 0.2353 | 0.1475 | 0.0249 | - | - |
| 现金及短投 | 6.71M | 7.80M | 7.18M | 2.91M | 5.55M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 1.20M | 696000.00 | 419000.00 | 8000.00 | - |
| 净债务 | -5.78M | -7.17M | 3.07M | 6.94M | 2.85M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -4.29M | -3.71M | -2.89M | -4.03M | -3.48M |
| 投资现金流 | -213000.00 | -249000.00 | -2.56M | - | - |
| 融资现金流 | 3.42M | 4.58M | 9.73M | 1.39M | 7.58M |
| 自由现金流 | -5.68M | -1.25M | -5.65M | 4.01M | 1.56M |
| 现金流充裕率 | - | -2411.04% | - | -5443.24% | -1087.50% |
| 举债与偿债 | - | 0.0000 | -225000.00 | 452000.00 | - |
| 资本支出 | - | - | - | - | - |